CSIMarket
 


Instil Bio Inc   (TIL)
Other Ticker:  
 
 

TIL's Net Income Growth by Quarter and Year

Instil Bio Inc 's Net Income results by quarter and year




TIL Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -53.84 -55.35 -0.98
III Quarter September -67.43 -56.22 -43.01 -2.99
II Quarter June -18.66 -58.99 -35.31 -0.08
I Quarter March -57.07 -54.12 -23.13 0.22
FY   -143.16 -223.17 -156.80 -3.83



TIL Net Income third quarter 2023 Y/Y Growth Comment
Instil Bio Inc in the third quarter 2023 recorded net loss of $ -67.43 millions.

According to the results reported in the third quarter 2023, Instil Bio Inc achieved the best Net Income growth in Biotechnology & Pharmaceuticals industry. While Instil Bio Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2023.




TIL Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Instil Bio Inc 's third quarter 2023 Net Income $ -67.43 millions TIL's Income Statement
Instil Bio Inc 's third quarter 2022 Net Income $ -56.22 millions Quarterly TIL's Income Statement
New: More TIL's historic Net Income Growth >>


TIL Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Instil Bio Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TIL's III. Quarter Q/Q Net Income Comment
Recent accomplishment of -67.43 millions by Instil Bio Inc appear even more unfavourable considering the -18.66 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Instil Bio Inc achieved highest sequential Net Income growth. While Instil Bio Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TIL's III. Quarter Q/Q Net Income Comment
III. Quarter 2023 net loss of -67.43 millions by Instil Bio Inc appear even less good if you take a look at -18.66 millions net loss in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Instil Bio Inc achieved highest sequential Net Income growth. While Instil Bio Inc 's Net Income growth quarter on quarter, overall rank is .


Instil Bio Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Income 12 Months Ending $ -197.01 $ -185.80 $ -226.13 $ -223.18 $ -224.68
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment


Instil Bio Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment


Instil Bio Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
TIL's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for TIL's Competitors
Net Income Growth for Instil Bio Inc 's Suppliers
Net Income Growth for TIL's Customers

You may also want to know
TIL's Annual Growth Rates TIL's Profitability Ratios TIL's Asset Turnover Ratio TIL's Dividend Growth
TIL's Roe TIL's Valuation Ratios TIL's Financial Strength Ratios TIL's Dividend Payout Ratio
TIL's Roa TIL's Inventory Turnover Ratio TIL's Growth Rates TIL's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2023
West Pharmaceutical Services Inc 33.75%$ 33.748 millions
Addus Homecare Corporation33.51%$ 33.509 millions
Halozyme Therapeutics Inc 32.78%$ 32.779 millions
Chemed Corporation31.80%$ 31.799 millions
Intuitive Surgical Inc 29.29%$ 29.289 millions
Gilead Sciences Inc 21.61%$ 21.613 millions
Neurocrine Biosciences Inc 21.31%$ 21.314 millions
Docgo Inc 20.50%$ 20.505 millions
Progyny Inc 20.34%$ 20.339 millions
Bristol myers Squibb Company20.27%$ 20.274 millions
Dexcom Inc 19.27%$ 19.269 millions
Idexx Laboratories Inc17.29%$ 17.295 millions
Biomx Inc 16.61%$ 16.608 millions
Ensign Group Inc13.74%$ 13.737 millions
Zoetis Inc 12.88%$ 12.879 millions
United Therapeutics Corporation11.83%$ 11.826 millions
Edwards Lifesciences Corporation11.70%$ 11.703 millions
Vertex Pharmaceuticals Inc11.26%$ 11.263 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com